| Literature DB >> 24987417 |
Mihai Harza1, Sebastian Voinea1, Gener Ismail2, Cristian Gagiu1, Catalin Baston1, Adrian Preda1, Ioan Manea1, Tiberiu Priporeanu1, Ioanel Sinescu1.
Abstract
Primary epididymal obstructive azoospermia (OA) is the most prevalent form of OA in nonvasectomized patients and has been less studied. We aim to assess the results with microsurgical vasoepididymostomy used in the treatment of men diagnosed with primary epididymal obstructive azoospermia and to identify the factors associated with natural pregnancy occurring after microsurgical reconstruction. This prospective study included consecutive patients with epididymal OA who underwent microsurgical reconstruction in our center. Clinical and biological data were obtained every three months during follow-up. Occurrence of natural pregnancy was the primary study outcome. In total, 36 patients underwent microsurgical reconstruction. The mean age was 34 ± 4.5 years (range 24-46 years). Median follow-up time was 15 [IQR 12-21] months. The total patency rate was 77.7% (n = 28). During follow-up, 8 (22.2%) natural pregnancies occurred. The overall live birth rate was 100%. Low FSH levels (HR: 0.22; 95% CI: 0.052-0.88; P = 0.032) and higher total motile sperm count (TMSC) (HR: 1.001; 95% CI 1-1.001; P = 0.012) were associated with a higher rate of natural pregnancy. Our data suggest that microsurgical vasoepididymostomy is an effective therapy of primary epididymal OA. Baseline lower FSH and higher TMSC were independent predictors for natural pregnancy occurrence.Entities:
Year: 2014 PMID: 24987417 PMCID: PMC4058594 DOI: 10.1155/2014/873527
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
Figure 1Patient selection.
Investigated parameters in study groups.
| All | With patency | With natural pregnancy | Without natural pregnancy |
| |
|---|---|---|---|---|---|
| Patients (number) | 36 | 28 | 8 | 20 | |
| Age (years) | 34 [31–37] | 33 [31–33] | 30 [26–33] | 37 [35–40] | 0.145 |
| Age of female partners (years) | 32 [29–36] | 31 [29–31] | 30 [28.25–34.75] | 31.5 [29–35.5] | 0.411 |
| Smokers (% yes) | 38.9 | 39.3 | 62.5 | 30 | 0.199 |
| Prior fertility status (% yes) | 11.1 | 14.3 | 25 | 10 | 0.556 |
| Medical history of urological infections (% yes) | 44.4 | 53.6 | 37.5 | 60 | 0.381 |
| FSH (UI/L) | 3.86 ± 1.74 | 3.86 ± 1.66 | 2.84 ± 1.23 | 4.27 ± 1.66 | 0.023 |
| LH (UI/L) | 4.05 ± 1.58 | 4.1 ± 1.7 | 4.23 ± 1.69 | 4.00 ± 1.79 | 0.754 |
| Testosterone (ng/mL) | 5.70 ± 1.84 | 5.75 ± 1.9 | 5.47 ± 2.67 | 5.88 ± 1.67 | 0.701 |
| Right testicular volume (cm3) | 14.67 ± 5.38 | 14.57 ± 5.99 | 16.89 ± 3.97 | 13.59 ± 6.51 | 0.122 |
| Left testicular volume (cm3) | 13.92 ± 6.97 | 14.77 ± 7.03 | 16.73 ± 4.39 | 13.94 ± 6.84 | 0.251 |
| Thickness of the right epididymis (mm) | 8.90 ± 3.62 | 8.51 ± 3.40 | 8.75 ± 2.07 | 8.39 ± 3.95 | 0.775 |
| Thickness of the left epididymis (mm) | 8.68 ± 3.56 | 8.81 ± 3.27 | 9.66 ± 1.07 | 8.39 ± 3.90 | 0.238 |
| TMSC (×106) | 0 | 50.14 ± 46.45 | 114.11 ± 37.65 | 24.55 ± 11.51 | 0.0001 |
TMSC: total motile sperm count, FSH: follicle stimulating hormone, and LH: luteinizing hormone.
*With natural pregnancy versus without natural pregnancy.
Results of multivariate Cox proportional hazard model analysis.
| Variable | Sig.( | Exp( | 95.0% CI for Exp( |
|---|---|---|---|
| Age | 0.163 | 1.543 | 0.839–2.838 |
| Age of female partners | 0.123 | 0.552 | 0.259–1.175 |
| Medical history of urological infections (yes) | 0.754 | 0.530 | 0.010–27.989 |
| Prior fertility status (yes) | 0.778 | 0.599 | 0.017–21.068 |
| FSH | 0.032 | 0.215 | 0.052–0.879 |
| LH | 0.114 | 4.019 | 0.715–22.581 |
| Testosterone | 0.465 | 0.799 | 0.438–1.459 |
| TMSC | 0.012 | 1.001 | 1.000–1.001 |
TMSC: total motile sperm count; FSH: follicle stimulating hormone; LH: luteinizing hormone.
Figure 2TMSC diagnostic utility for natural pregnancy occurrence (ROC analysis).
Figure 3FSH diagnostic utility for natural pregnancy occurrence (ROC analysis).